<p>随着全球市场在复杂的环境中航行，亚洲经济体仍然是寻求多样化机会的投资者的焦点。尽管小盘股通常与较小或新兴公司相关联，但它们仍然提供了引人注目的潜力。通过关注那些财务稳健且增长轨迹明确的公司，这些股票可以在更广泛的市场中呈现出隐藏的宝藏。</p>
<h3>亚洲十大小盘股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>YKGI (Catalist:YK9)</td>
<td>SGD0.099</td>
<td>SGD42.08M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.14</td>
<td>HK$719.28M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Ever Sunshine Services Group (SEHK:1995)</td>
<td>HK$1.89</td>
<td>HK$3.27B</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.06</td>
<td>HK$1.72B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD0.44</td>
<td>SGD178.33M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Goodbaby International Holdings (SEHK:1086)</td>
<td>HK$1.17</td>
<td>HK$1.95B</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD2.29</td>
<td>SGD9.01B</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Beng Kuang Marine (SGX:BEZ)</td>
<td>SGD0.179</td>
<td>SGD35.66M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>BRC Asia (SGX:BEC)</td>
<td>SGD3.13</td>
<td>SGD858.72M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.39</td>
<td>HK$50.29B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们亚洲小盘股筛选器中的 1,153 只股票的完整列表。</p>
<p>让我们探索筛选结果中的几个突出选项。</p>
<h2>Viva Goods (SEHK:933)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Viva Goods Company Limited 是一家投资控股公司，向包括英国、爱尔兰、美国、中国、亚洲、欧洲、中东和非洲在内的多个地区供应服装和鞋类，市值为 HK$33.9 亿。</p>
<p><strong>运营：</strong> 该公司通过两个主要部门产生收入：体育体验，贡献 HK$5.593 亿，以及多品牌服装和鞋类，贡献 HK$98.7 亿。</p>
<p><strong>市值：</strong> HK$33.9B</p>
<p>Viva Goods Company Limited 的市值为 HK$33.9 亿，业务涵盖多个地区的服装和鞋类行业。该公司报告 2024 年的收入为 HK$104.3 亿，但仍处于亏损状态，净亏损为 HK$7041 万，尽管这比去年有所改善。最近的股票回购公告可能通过提高每股净资产和每股收益来增强股东价值。尽管面临亏损，Viva Goods 的现金状况良好，超过其债务，并有效覆盖短期和长期负债，资产总额为 HK$50 亿，短期负债为 HK$35 亿，长期负债为 HK$20 亿。</p>
<ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 Viva Goods 的动态。</li>
<li>通过我们的公司历史业绩报告，深入了解 Viva Goods 的过去趋势和表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis"/></p>
<p>SEHK:933 债务与股本历史及分析截至 2025 年 6 月</p>
<h2>青海春天药用资源科技 (SHSE:600381)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 青海春天药用资源科技有限公司在药用资源领域运营，市值约为 CN¥24.9 亿。</p>
<p><strong>运营：</strong> 青海春天药用资源科技有限公司尚未报告任何具体的收入部门。</p>
<p><strong>市值：</strong> CN¥24.9B</p>
<p>青海春天药用资源科技的市值为 CN¥24.9 亿，尽管近年来处于亏损状态，但显示出财务改善的迹象。该公司报告 2025 年第一季度净收入为 CN¥892 万，与去年亏损形成对比，2024 年年收入从 CN¥2.1388 亿增长至 CN¥2.7026 亿。其强劲的现金状况覆盖了短期负债（CN¥7090 万）和长期负债（CN¥290 万），而无债务的状态在收益波动和负股本回报率（-15.54%）中增强了财务稳定性。管理层的经验进一步支持潜在的运营韧性。</p>
<ul>
<li>点击这里查看完整的健康分析报告，以更深入了解青海春天药用资源科技。</li>
<li>查看我们的历史业绩报告，以获取青海春天药用资源科技的业绩记录的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown"/></p>
<p>SHSE:600381 收入与支出分解截至 2025 年 6 月</p>
<h2>Lecron 工业发展集团 (SZSE:300343)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Lecron 工业发展集团有限公司在工业发展领域运营，市值为 CN¥45.4 亿。</p>
<p><strong>运营：</strong> Lecron 工业发展集团有限公司尚未报告任何具体的收入部门。</p>
<p><strong>市值：</strong> CN¥45.4B</p>
<p>Lecron 工业发展集团最近的财务表现表明盈利能力的转变，2025 年第一季度净收入为 CN¥502 万，而去年则出现亏损。尽管这一积极转变，但公司面临低股本回报率（2.1%）和负经营现金流等挑战，这影响了债务覆盖。然而，其短期资产 CN¥13 亿显著超过负债，为其提供了一定的财务缓冲。该公司还启动了一项高达 1 亿人民币的股票回购计划，以支持股权激励，同时其经验丰富的管理团队在高股票波动中提供潜在的稳定性。</p>
<ul>
<li>在这里深入了解乐创工业发展集团的详细资产负债表健康报告。</li>
<li>通过我们详细的历史业绩报告评估乐创工业发展集团的过去业绩。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis"/></p>
<p>SZSE:300343 财务状况分析截至 2025 年 6 月</p>
<h2>让它发生</h2>
<ul>
<li>点击这里开始探索其余的 1,150 只亚洲便士股票。</li>
<li>准备好进入其他投资风格了吗？探索 22 家在量子计算领域引领革命的顶尖公司，推动下一代技术的发展，并在量子算法、超导量子比特和前沿研究方面取得突破。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

非凡领越

*ST春天

<p>亚洲市场吸引投资者关注有前景的低价股票，尽管存在风险。值得一提的是，非凡领越在服装和鞋类领域运营，市值为 33.9 亿港元，预计 2024 年收入为 104.3 亿港元，但净亏损为 7041 万港元。青海春天药用资源科技的估值为 24.9 亿人民币，2025 年第一季度净收入为 892 万元，显示出财务改善。乐创工业发展集团市值为 45.4 亿人民币，已转向盈利，2025 年第一季度净收入为 502 万元。投资者被鼓励进一步探索这些机会</p>

<p>As global markets navigate a complex landscape, Asian economies remain a focal point for investors seeking diverse opportunities. Penny stocks, often associated with smaller or emerging companies, continue to offer intriguing potential despite their vintage label. By focusing on those with robust financials and clear growth trajectories, these stocks can present hidden gems within the broader market landscape.</p>
<div class="lb-trans"><p>随着全球市场在复杂的环境中航行，亚洲经济体仍然是寻求多样化机会的投资者的焦点。尽管小盘股通常与较小或新兴公司相关联，但它们仍然提供了引人注目的潜力。通过关注那些财务稳健且增长轨迹明确的公司，这些股票可以在更广泛的市场中呈现出隐藏的宝藏。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亚洲十大小盘股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>YKGI (Catalist:YK9)</td>
<td>SGD0.099</td>
<td>SGD42.08M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.14</td>
<td>HK$719.28M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Ever Sunshine Services Group (SEHK:1995)</td>
<td>HK$1.89</td>
<td>HK$3.27B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.06</td>
<td>HK$1.72B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD0.44</td>
<td>SGD178.33M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Goodbaby International Holdings (SEHK:1086)</td>
<td>HK$1.17</td>
<td>HK$1.95B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD2.29</td>
<td>SGD9.01B</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Beng Kuang Marine (SGX:BEZ)</td>
<td>SGD0.179</td>
<td>SGD35.66M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>BRC Asia (SGX:BEC)</td>
<td>SGD3.13</td>
<td>SGD858.72M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.39</td>
<td>HK$50.29B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>YKGI (Catalist:YK9)</td>
<td>SGD0.099</td>
<td>SGD42.08M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.14</td>
<td>HK$719.28M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Ever Sunshine Services Group (SEHK:1995)</td>
<td>HK$1.89</td>
<td>HK$3.27B</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.06</td>
<td>HK$1.72B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD0.44</td>
<td>SGD178.33M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Goodbaby International Holdings (SEHK:1086)</td>
<td>HK$1.17</td>
<td>HK$1.95B</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD2.29</td>
<td>SGD9.01B</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Beng Kuang Marine (SGX:BEZ)</td>
<td>SGD0.179</td>
<td>SGD35.66M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>BRC Asia (SGX:BEC)</td>
<td>SGD3.13</td>
<td>SGD858.72M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.39</td>
<td>HK$50.29B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 1,153 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们亚洲小盘股筛选器中的 1,153 只股票的完整列表。</p>
</div><p>Let's explore several standout options from the results in the screener.</p>
<div class="lb-trans"><p>让我们探索筛选结果中的几个突出选项。</p>
</div><h2>Viva Goods (SEHK:933)</h2>
<div class="lb-trans"><h2>Viva Goods (SEHK:933)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Viva Goods Company Limited is an investment holding company that supplies apparel and footwear across various regions including the United Kingdom, the Republic of Ireland, the United States, China, Asia, Europe, the Middle East, and Africa with a market cap of HK$3.39 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Viva Goods Company Limited 是一家投资控股公司，向包括英国、爱尔兰、美国、中国、亚洲、欧洲、中东和非洲在内的多个地区供应服装和鞋类，市值为 HK$33.9 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue through two main segments: Sports Experience, contributing HK$559.30 million, and Multi-Brand Apparel and Footwear, which accounts for HK$9.87 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过两个主要部门产生收入：体育体验，贡献 HK$5.593 亿，以及多品牌服装和鞋类，贡献 HK$98.7 亿。</p>
</div><p><strong>Market Cap:</strong> HK$3.39B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$33.9B</p>
</div><p>Viva Goods Company Limited, with a market cap of HK$3.39 billion, operates in the apparel and footwear sectors across various regions. The company reported revenues of HK$10.43 billion for 2024 but remains unprofitable with a net loss of HK$70.41 million, though this is an improvement from the previous year. Recent share repurchase announcements could enhance shareholder value by increasing net asset value per share and earnings per share. Despite its losses, Viva Goods has a strong cash position exceeding its debt and covers both short-term and long-term liabilities effectively with assets totaling HK$5 billion against liabilities of HK$3.5 billion short-term and HK$2 billion long-term.</p>
<div class="lb-trans"><p>Viva Goods Company Limited 的市值为 HK$33.9 亿，业务涵盖多个地区的服装和鞋类行业。该公司报告 2024 年的收入为 HK$104.3 亿，但仍处于亏损状态，净亏损为 HK$7041 万，尽管这比去年有所改善。最近的股票回购公告可能通过提高每股净资产和每股收益来增强股东价值。尽管面临亏损，Viva Goods 的现金状况良好，超过其债务，并有效覆盖短期和长期负债，资产总额为 HK$50 亿，短期负债为 HK$35 亿，长期负债为 HK$20 亿。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Viva Goods.</li>
<li>Gain insights into Viva Goods' past trends and performance with our report on the company's historical track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 Viva Goods 的动态。</li>
<li>通过我们的公司历史业绩报告，深入了解 Viva Goods 的过去趋势和表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/e538d9f2-cc1a-4cca-8f73-949327457f48/chart/debt-equity-history-analysis"/></p>
<p>SEHK:933 Debt to Equity History and Analysis as at Jun 2025</p>
<div class="lb-trans"><p>SEHK:933 债务与股本历史及分析截至 2025 年 6 月</p>
</div><h2>Qinghai Spring Medicinal Resources Technology (SHSE:600381)</h2>
<div class="lb-trans"><h2>青海春天药用资源科技 (SHSE:600381)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥2.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 青海春天药用资源科技有限公司在药用资源领域运营，市值约为 CN¥24.9 亿。</p>
</div><p><strong>Operations:</strong> Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>运营：</strong> 青海春天药用资源科技有限公司尚未报告任何具体的收入部门。</p>
</div><p><strong>Market Cap:</strong> CN¥2.49B</p>
<div class="lb-trans"><p><strong>市值：</strong> CN¥24.9B</p>
</div><p>Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥2.49 billion, shows signs of financial improvement despite its unprofitable status over recent years. The company reported a net income of CN¥8.92 million for Q1 2025, contrasting with a loss the previous year, and annual revenue growth from CN¥213.88 million to CN¥270.26 million in 2024. Its strong cash position covers both short-term liabilities (CN¥70.9M) and long-term liabilities (CN¥2.9M), while remaining debt-free enhances financial stability amidst volatility in earnings and negative return on equity (-15.54%). Management's experience further supports potential operational resilience.</p>
<div class="lb-trans"><p>青海春天药用资源科技的市值为 CN¥24.9 亿，尽管近年来处于亏损状态，但显示出财务改善的迹象。该公司报告 2025 年第一季度净收入为 CN¥892 万，与去年亏损形成对比，2024 年年收入从 CN¥2.1388 亿增长至 CN¥2.7026 亿。其强劲的现金状况覆盖了短期负债（CN¥7090 万）和长期负债（CN¥290 万），而无债务的状态在收益波动和负股本回报率（-15.54%）中增强了财务稳定性。管理层的经验进一步支持潜在的运营韧性。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Qinghai Spring Medicinal Resources Technology.</li>
<li>Review our historical performance report to gain insights into Qinghai Spring Medicinal Resources Technology's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里查看完整的健康分析报告，以更深入了解青海春天药用资源科技。</li>
<li>查看我们的历史业绩报告，以获取青海春天药用资源科技的业绩记录的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/b8d882ec-29ca-4e22-a8bf-7a25aee42fef/chart/revenue-and-expenses-breakdown"/></p>
<p>SHSE:600381 Revenue &amp; Expenses Breakdown as at Jun 2025</p>
<div class="lb-trans"><p>SHSE:600381 收入与支出分解截至 2025 年 6 月</p>
</div><h2>Lecron Industrial Development Group (SZSE:300343)</h2>
<div class="lb-trans"><h2>Lecron 工业发展集团 (SZSE:300343)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Lecron Industrial Development Group Co., Ltd. operates in the industrial development sector and has a market cap of CN¥4.54 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Lecron 工业发展集团有限公司在工业发展领域运营，市值为 CN¥45.4 亿。</p>
</div><p><strong>Operations:</strong> Lecron Industrial Development Group Co., Ltd. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>运营：</strong> Lecron 工业发展集团有限公司尚未报告任何具体的收入部门。</p>
</div><p><strong>Market Cap:</strong> CN¥4.54B</p>
<div class="lb-trans"><p><strong>市值：</strong> CN¥45.4B</p>
</div><p>Lecron Industrial Development Group's recent financial performance indicates a shift to profitability, with Q1 2025 net income at CN¥5.02 million compared to a loss the previous year. Despite this positive turn, the company faces challenges like low return on equity (2.1%) and negative operating cash flow, which impacts debt coverage. However, its short-term assets of CN¥1.3 billion significantly exceed liabilities, providing some financial cushion. The company has also initiated a share buyback program worth up to CN¥100 million to support equity incentives, while its experienced management team offers potential stability amidst high stock volatility.</p>
<div class="lb-trans"><p>Lecron 工业发展集团最近的财务表现表明盈利能力的转变，2025 年第一季度净收入为 CN¥502 万，而去年则出现亏损。尽管这一积极转变，但公司面临低股本回报率（2.1%）和负经营现金流等挑战，这影响了债务覆盖。然而，其短期资产 CN¥13 亿显著超过负债，为其提供了一定的财务缓冲。该公司还启动了一项高达 1 亿人民币的股票回购计划，以支持股权激励，同时其经验丰富的管理团队在高股票波动中提供潜在的稳定性。</p>
</div><ul>
<li>Dive into the specifics of Lecron Industrial Development Group here with our thorough balance sheet health report.</li>
<li>Assess Lecron Industrial Development Group's previous results with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解乐创工业发展集团的详细资产负债表健康报告。</li>
<li>通过我们详细的历史业绩报告评估乐创工业发展集团的过去业绩。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/9c6ebac5-98d5-4d0e-a541-c746592e8fd2/chart/financial-position-analysis"/></p>
<p>SZSE:300343 Financial Position Analysis as at Jun 2025</p>
<div class="lb-trans"><p>SZSE:300343 财务状况分析截至 2025 年 6 月</p>
</div><h2>Make It Happen</h2>
<div class="lb-trans"><h2>让它发生</h2>
</div><ul>
<li>Click through to start exploring the rest of the 1,150 Asian Penny Stocks now.</li>
<li>Ready To Venture Into Other Investment Styles? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里开始探索其余的 1,150 只亚洲便士股票。</li>
<li>准备好进入其他投资风格了吗？探索 22 家在量子计算领域引领革命的顶尖公司，推动下一代技术的发展，并在量子算法、超导量子比特和前沿研究方面取得突破。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

亚洲市场洞察：非凡领越及其他两只知名便士股